Rubaiya Anika | Health | Innovative Research Award

Innovative Research Award

Rubaiya Anika
Mount Sinai Hospital, United States

Rubaiya Anika
Affiliation Mount Sinai Hospital
Country United States
Documents 1
Subject Area Health
Event International Research Hypothesis Excellence Award
ORCID 0009-0005-9072-732X

Rubaiya Anika is a researcher affiliated with Mount Sinai Hospital in the United States whose documented research contribution addresses environmental exposure and biological aging. Her listed journal article examines urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration among U.S. adults using data from the National Health and Nutrition Examination Survey (NHANES) covering 1999–2018. The work was published in the International Journal of Environmental Research and Public Health in August 2026 and provides a research contribution at the intersection of environmental health, exposure science, epidemiology, and aging research. [1]

Abstract

The research contribution associated with Rubaiya Anika investigates the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration in U.S. adults. The study, titled Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018, uses population-based NHANES data to examine an environmental exposure question within an aging-related epidemiological framework. The article was published in the International Journal of Environmental Research and Public Health in August 2026 and is identified by DOI 10.3390/ijerph23091126. [1]

Keywords

  • Innovative Research Award
  • Rubaiya Anika
  • Organophosphate metabolites
  • Phenotypic aging
  • Environmental health

Introduction

Environmental exposures are an important area of public-health research because chemical exposures may vary across populations and may be investigated in relation to measurable biological and health outcomes. Organophosphate metabolites measured in urine can serve as biomarkers of exposure to organophosphate compounds, while phenotypic measures of aging can provide quantitative indicators for studying biological aging in epidemiological populations. The reported study brings these concepts together by analyzing nationally collected U.S. health data across multiple NHANES cycles from 1999 through 2018. [1]

Research Profile

Rubaiya Anika is identified in the supplied publication record as an author affiliated with Mount Sinai Hospital, United States. The documented subject area is Health, with the research contribution positioned within environmental and population health. The available publication record contains one indexed document supplied for this recognition profile.[1]

Research Contributions

The principal documented contribution is the study of urinary organophosphate metabolites in relation to laboratory-derived phenotypic aging acceleration. This research connects environmental exposure assessment with an aging-related outcome and uses nationally collected health-survey data as its analytical foundation. [1]

  • Evaluation of urinary organophosphate metabolite measurements as indicators of environmental exposure.
  • Investigation of phenotypic aging acceleration as a measurable aging-related outcome.
  • Use of NHANES data spanning 1999–2018 to support population-based analysis.
  • Integration of environmental epidemiology and biological aging research.[1]

Publications

The available record identifies one journal article associated with Rubaiya Anika:

Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018

The publication lists Rubaiya Anika, Matthew Untalan, Emanuela Taioli, and Stephanie Tuminello as contributors. The DOI provides a persistent identifier for the journal article and supports direct access to its bibliographic record. [1]

Research Impact

The documented research has potential relevance to environmental and population health because it investigates whether measurable environmental exposure biomarkers are associated with an aging-related phenotype in adults. Research of this type can contribute to hypothesis generation, exposure surveillance, and the identification of questions that may warrant further investigation through longitudinal, mechanistic, or experimental studies. [1]

Award Suitability

The documented publication provides a substantive basis for considering Rubaiya Anika for recognition under an Innovative Research Award framework. The work applies an interdisciplinary research approach by connecting environmental exposure biomarkers with a quantitative indicator of phenotypic aging in a U.S. adult population. [1]

  • Research innovation: The study links environmental exposure assessment with laboratory-derived phenotypic aging measures.
  • Interdisciplinary relevance: The research spans environmental health, epidemiology, exposure science, and aging research.
  • Population relevance: NHANES provides a nationally collected U.S. population dataset for epidemiological investigation.
  • Research communication: The work is documented through a peer-reviewed journal publication with a persistent DOI.
  • Future research value: The findings can help motivate additional research into environmental determinants of biological aging.

Conclusion

Rubaiya Anika’s documented research contribution focuses on the relationship between urinary organophosphate metabolites and laboratory-derived phenotypic aging acceleration among U.S. adults using NHANES data from 1999–2018. The resulting publication demonstrates an interdisciplinary approach to environmental and population health research and provides a basis for further investigation of environmental influences on aging-related outcomes. [1]

References

  1. Anika, R., Untalan, M., Taioli, E., & Tuminello, S. (2026). Urinary Organophosphate Metabolites and Laboratory-Derived Phenotypic Aging Acceleration in U.S. Adults: Evidence from NHANES 1999–2018. International Journal of Environmental Research and Public Health, 23(9), 1126.
    https://doi.org/10.3390/ijerph23091126

Esra Seyran | Medical Hypotheses | Best Researcher Award

Assist. Prof. Dr. Esra Seyran | Medical Hypotheses | Best Researcher Award

Assistant Professor at Cumhuriyet University, Turkey

Dr. Esra Seyran is a distinguished molecular biologist and biochemist currently serving as an Assistant Professor at Cumhuriyet University, Turkey. With a Ph.D. in Biochemistry and Molecular Biology from the University of Arkansas, USA, her academic journey spans diverse fields including plant science, protein chemistry, and nanotechnology. She brings extensive international experience, notably as a Scientific Project Officer at the European Commission’s Joint Research Center in Belgium, where she contributed to biosafety and GMO policy development. Dr. Seyran has a strong research portfolio with over 15 publications in high-impact journals, focusing on recombinant protein expression, disease biomarkers, antifungal targets, and nanoparticle-based therapeutic and industrial applications. Her work has earned her prestigious fellowships from institutions such as the United Nations, FAO, and NSF. Notably, she holds a 2023 Turkish patent for a nanomaterial-based COVID-19 treatment formulation. A dedicated educator with two decades of teaching experience in the U.S. and Turkey, Dr. Seyran exemplifies academic excellence, innovation, and interdisciplinary research leadership.

Professional Profile 

🎓 Education of Dr. Esra Seyran

Dr. Esra Seyran has pursued a rich and multidisciplinary academic path across prestigious institutions in the USA, Italy, and Turkey. She earned her Ph.D. in Biochemistry and Molecular Biology (2006–2011) from the University of Arkansas, where her dissertation focused on the expression, purification, and redox-dependent disulfide bonding in human Von Willebrand Factor A domains. Prior to that, she completed her M.Sc. in Plant Science (2002–2005) at the same university, with research on temperature interactions in Puccinia striiformis isolates. In 2000–2001, she undertook a post-bachelor’s specialization in Plant-Microbe Interactions at the Instituto Agronomico Mediterraneo di Bari in Italy, supported by an Italian Foreign Ministry Fellowship. Her academic foundation was laid with a B.Sc. in Biochemistry from Ege University, Izmir, Turkey (1993–1999). This diverse and international educational background has empowered her to work at the intersection of molecular biology, plant pathology, and biochemical research.

💼 Professional Experience of Dr. Esra Seyran

Dr. Esra Seyran has amassed a diverse and impactful professional career spanning academia, international research institutions, and policy advisory roles. She currently serves as an Assistant Professor at Cumhuriyet University’s Department of Molecular Biology and Genetics in Turkey, where she has been a faculty member since 2014. Prior to her current role, she worked as an Instructor at the same university from 2014 to 2021, teaching advanced courses in biochemistry, toxicology, and genetics. Between 2011 and 2013, Dr. Seyran held the position of Scientific Project Officer at the European Commission’s Joint Research Center (DG-JRC) in Geel, Belgium, where she provided policy advice on biosafety, GMOs, and pesticide regulation, while contributing to capacity-building efforts in alignment with EU standards. Her early career includes roles as a Teaching Assistant in the Department of Chemistry and Biochemistry (2006–2011) and a Research Assistant in Plant Pathology (2002–2005) at the University of Arkansas, where she also engaged in undergraduate instruction across a range of chemistry and biochemistry subjects. This blend of research, teaching, and international policy work reflects Dr. Seyran’s multifaceted expertise and professional versatility.

🔬 Research Interests of Dr. Esra Seyran

Dr. Esra Seyran’s research interests lie at the intersection of biochemistry, molecular biology, plant pathology, and nanotechnology, with a strong emphasis on translational and interdisciplinary science. Her work focuses on recombinant protein expression and purification, particularly the structural and functional analysis of Von Willebrand Factor domains, which has implications in cardiovascular and hematological disorders. She is also deeply involved in studying biochemical markers for metabolic and macrovascular diseases, such as diabetes. Dr. Seyran explores site-specific protein modifications, such as glycation and acetylation, and their impact on drug-protein interactions. Additionally, she has contributed to the development of nanoparticle-based materials for both therapeutic applications (e.g., COVID-19 treatment formulations) and industrial innovations, including corrosion inhibitors. Her early research in plant-microbe interactions and fungal pathogens also reflects a continued interest in agricultural biotechnology and host-pathogen dynamics. With this broad yet integrated focus, Dr. Seyran aims to bridge fundamental biochemical research with real-world applications in medicine, agriculture, and material science.

🏅 Awards and Honors of Dr. Esra Seyran

Dr. Esra Seyran has been recognized with numerous prestigious awards and fellowships throughout her academic and professional journey, reflecting her excellence in research, innovation, and international collaboration. In 2016, she was honored with the United Nations Arturo Falaschi Research Fellowship, acknowledging her contributions to molecular biology. She also received the FAO Training Fellowship in 2012 for her work on obsolete pesticide management. During her doctoral studies, she was awarded the Distinguished Doctoral Fellowship by the University of Arkansas Department of Chemistry in 2007, and the same year secured a National Science Foundation Scholarship for advanced training in microbial genetics at the Craig Venter Institute. Earlier accolades include the Asia Rice Foundation Research Award in 2006, and the Graduate School Travel Award from the University of Arkansas in 2004. Dr. Seyran also benefited from the Italian Foreign Ministry Cultural Exchange Scholarship (2000–2001), which supported her studies in plant-microbe interactions in Italy. These honors highlight her outstanding academic potential, international impact, and dedication to scientific advancement.

🏁 Conclusion

Dr. Esra Seyran presents a highly competitive and well-rounded profile suitable for the Best Researcher Award. Her work bridges cutting-edge biochemistry, biomedical innovation, agricultural science, and public policy, making her a rare multidisciplinary contributor. Her global research footprint, commitment to teaching, technical competencies, and novel contributions (e.g., patent) strongly support her eligibility and worthiness for recognition.

📚 Publications Top Noted

  1. Title: Aggressiveness of Puccinia striiformis f. sp. tritici isolates in the south-central United States
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 190
  2. Title: New breeding techniques and their possible regulation
    Authors: E Seyran, W Craig
    Year: 2018
    Cited by: 23
  3. Title: Examination of the rice blast pathogen population diversity in Arkansas, USA – Stable or unstable?
    Authors: JC Correll, EJ Boza, E Seyran, RD Cartwright, Y Jia, FN Lee
    Year: 2009
    Cited by: 20
  4. Title: A preliminary characterization of the rice blast fungus on ‘Banks’ rice
    Authors: FN Lee, RD Cartwright, Y Jia, JC Correll, KAK Moldenhauer, JW Gibbons, V Boyett, E Zhou, E Boza, E Seyran
    Year: 2004
    Cited by: 20
  5. Title: New Races of Puccinia striiformis f. sp. tritici More Aggressive Than Older Races
    Authors: ESE Milus
    Year: 2005
    Cited by: 9
  6. Title: Aggressiveness of Puccinia striiformis f. sp. tritici
    Authors: EA Milus, E Seyran, R McNew
    Year: 2006
    Cited by: 3
  7. Title: Fungal homoserine transacetylase: a potential antifungal target
    Authors: E Seyran
    Year: 2021
    Cited by: 2
  8. Title: Isolate by temperature interaction for aggressiveness among isolates of Puccinia striiformis f. sp. tritici
    Authors: E Seyran, EA Milus
    Year: 2004
    Cited by: 2
  9. Title: The effects of aspirin acetylation of human serum albumin on its interactions with methotrexate
    Authors: Esra Seyran, Serap Cetinkaya
    Year: 2025
    Cited by: 1
  10. Title: Nanoparticle-Based Corrosion Inhibitors
    Authors: E Seyran, G Tüzün, S Çetinkaya, B Tüzün
    Year: 2024
    Cited by: 1

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics 🧪. With a Master’s in Pharmacology 🎓 and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing 📚. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams 👩‍🔬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer 📝. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication 💪, and innovation 💡. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer 🖋️ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles 📄, pharmacological monographs 📑, systematic reviews 📚, and regulatory documents 🏛️. She specialized in herbal medicine 🌿, clinical data analysis 📊, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor 🎓 at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching 📚, mentoring students 🎯, curriculum development ✍️, and academic research 🧪. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🤝, reviewed manuscripts for leading journals 📰, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor 🔬, exceptional communication skills 🗣️, and regulatory precision 📏, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence 📚, leadership 🏅, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer 🖊️ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎤 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” 🔬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion 🏆 of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi 🎓. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics 💊. She has explored the anti-diabetic 🌟, anti-inflammatory 🧪, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments 🧘‍♀️ through evidence-based studies, clinical evaluation 📊, and data synthesis from ethnobotanical sources 📚. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication 🖋️, regulatory documentation 📑, and the development of novel therapeutics 🚀, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

  • 📄 Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.

  • 📄 Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.

  • 📄 Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.

  • 📄 Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.

  • 📄 Elevating the Inner-Consciousness “Third Eye” Through “Vedic Manas Yoga” Practice.

  • 📄 Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

  • 📚 Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.

  • 📚 Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.

  • 📚 Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.

  • 📚 Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.

  • 📚 Impact of Biosensors and Biomarkers in Diabetes Care: A Review.

  • 📚 Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.

  • 📚 Effect of Coliform Bacteria on Various Environmental Factors: A Review.

  • 📚 Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.

  • 📚 Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.

  • 📚 Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

 

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Wei Liu | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Wei Liu Hunan, University of Chinese Medicine, China

Prof. Dr. Wei Liu is a distinguished scholar in Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, serving as Deputy Dean at Hunan University of Chinese Medicine. With a Ph.D. in Engineering 🎓, he has made groundbreaking contributions through 100+ research papers 📄 (30+ indexed in SCI/EI), 2 monographs 📚, and 9 textbooks 📖. His 30+ software copyrights 💡 and leadership in 20+ major projects 🚀, including collaborations with Huawei and national research foundations, solidify his expertise. As a Young Backbone Teacher of Hunan Province, he also excels in mentoring, guiding students to 300+ awards 🏅, including 10+ national gold prizes 🏆. His teaching innovation has earned him national and provincial-level honors, while his contributions to Traditional Chinese Medicine (TCM) Informatics 🌿 further highlight his multidisciplinary excellence. Recognized as a National Certified System Architect 🏗️, SCI journal reviewer 🧐, and a member of CCF, ACM, and CAIS, Prof. Liu is a true leader in his field.

Publication Profile

Scopus

Education

Prof. Dr. Wei Liu holds a Ph.D. in Engineering (Computer Application Technology) 🖥️ from a prestigious institution, where he specialized in Artificial Intelligence 🤖 and Medical Informatics 🏥. His doctoral research focused on intelligent software systems, integrating machine learning 📊 with healthcare applications 🏩. Prior to his Ph.D., he completed his Master’s degree 🎓 in Computer Science, gaining deep expertise in data-driven decision-making 💾 and intelligent algorithms 🔍. His academic journey also includes undergraduate studies in Software Engineering 💡, where he built a strong foundation in computational intelligence 🧠, biomedical computing 🏥, and software development 💻. With an interdisciplinary education spanning engineering, computer science, and informatics, Prof. Liu combines technical depth with practical innovation, making his academic background perfectly suited for pioneering AI-driven healthcare solutions 🚑. His commitment to education 📚 continues as he mentors students and professionals in next-generation AI research and applications 🤖📊.

Experience

Prof. Dr. Wei Liu serves as the Deputy Dean of the School of Informatics 🏛️ at Hunan University of Chinese Medicine, leading research in Artificial Intelligence 🤖, Medical Informatics 🏥, and Software Engineering 💻. As a Professor and Senior Engineer 👨‍🔬, he supervises Master’s students 🎓, guiding them in cutting-edge AI research 🚀. With a rich teaching career 📚, he has developed three top-level provincial courses 🎖️ and ranked 1st in the Hunan Provincial Teaching Competition 🏆. His industry collaborations with Huawei and leadership in 20+ national projects 🏗️ highlight his practical impact 🌍. He actively contributes as a Vice President of the Hunan Association for TCM Informatics 🌿 and serves on multiple national AI and computing committees 🤝. His work as an SCI journal reviewer 🧐 and National Certified System Architect 🏗️ ensures that his research, teaching, and innovation continue to shape the future of AI-driven medical solutions 🔬.

Awards & Honors

Prof. Dr. Wei Liu is a distinguished researcher and educator 🌟, renowned for his contributions to AI, medical informatics, and teaching innovation 📚. His accolades include the National Teaching Innovation Competition Second Prize 🏆 (2024), 1st Place in the Hunan Provincial Teaching Competition 🎖️, and the National TCM Informatics Teaching Gold Prize 🏅. He has been honored as the “Most Knowledgeable Young Teacher” in Hunan Province 🏆 and recognized as a Young Backbone Teacher 👨‍🏫. A recipient of the Huawei Industry-Academia Collaboration Excellence Award 🏅, he also serves as an Executive Member of National AI Committees 🤖. His mentorship has led students to win 300+ awards 🏆, including over 10 national gold prizes 🥇. As a pioneer in AI-driven medical technologies 🌍, his impact extends across academia and industry 🚀.

Research Focus

Prof. Dr. Wei Liu’s research spans Artificial Intelligence 🤖, Medical Informatics 🏥, and Intelligent Software Engineering 💻, focusing on AI-driven healthcare solutions 📊, big data analysis 🏩, and intelligent diagnosis 🏥. His expertise includes AI-based disease prediction, NLP for medical data 📜, deep learning for medical imaging 🧠📸, and IoT-driven smart healthcare 🚑. Integrating AI with Traditional Chinese Medicine 🌿🤖, he pioneers innovative patient care solutions. With 30+ software copyrights 💡, 100+ high-impact publications 📄, and national-level projects—including Huawei collaborations 🚀—his work enhances precision medicine, diagnostics, and medical software applications 🌍, revolutionizing healthcare technology.

Publication Top Notes

Recognition of Hand-Drawn Hydrocarbon Structure Formulas Using Anchor-Free Detector

Classification of cold and hot medicinal properties of Chinese herbal medicines based on graph convolutional network

ChemReco: automated recognition of hand-drawn carbon–hydrogen–oxygen structures using deep learning

SQCS: A sustainable quality control system for spatial crowdsourcing via three-party evolutionary game: Theory and practice

Truth based three-tier Combinatorial Multi-Armed Bandit ecosystems for mobile crowdsensing

YoDe-Segmentation: automated noise-free retrieval of molecular structures from scientific publications